A study that claims the popular OsteoStrong program can help strengthen bones in post-menopausal women is "misleading", and ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

New degree paths were added at Southern Miss, Mississippi State and Delta State. Mississippi’s Board of Trustees for the Institutions of Higher Learning approved the creation of several new degree ...

The brand claims to identify these underlying causes and treat them using a blend of Ayurveda, dermatology, and nutrition.

OST-HER2 has received Rare Pediatric Disease Designation for osteosarcoma from the FDA. If it receives a conditional BLA via Accelerated Review before September 30, 2026, it will become eligible for a ...

Forte Biosciences (FBRX) stock soared on Monday after the clinical-stage biopharmaceutical company announced results from a Phase 1b trial of FB102. This is the company’s lead program designed to ...

Earning a healthy paycheck and enjoying the benefits of remote work is becoming increasingly common, proving that it’s ...